Insider · CIK 0001882877

Mahal Jeetinder Singh

Reports to the SEC for 1 company · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001882877

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-06	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+500K sh	—	—	500,000
2026-01-02	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+90K sh	—	—	90,000
2025-06-04	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+90K sh	—	—	90,000
2025-02-13	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+50K sh	—	—	50,000
2024-12-12	JSPRJasper Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	$7.10	+$6,390	25,909
2024-12-12	JSPRJasper Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−900 sh	$22.11	−$19.9K	25,009
2024-12-12	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	—	—	13,772
2024-09-12	JSPRJasper Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	$7.10	+$6,390	25,909
2024-09-12	JSPRJasper Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−900 sh	$21.23	−$19.1K	25,009
2024-09-12	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	—	—	14,672
2024-06-12	JSPRJasper Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	$7.10	+$6,390	25,909
2024-06-12	JSPRJasper Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−900 sh	$24.16	−$21.7K	25,009
2024-06-12	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	—	—	15,572
2024-03-12	JSPRJasper Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	$7.10	+$6,390	25,909
2024-03-12	JSPRJasper Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−900 sh	$26.44	−$23.8K	25,009
2024-03-12	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+900 sh	—	—	16,472
2024-02-15	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+40K sh	—	—	40,000
2023-10-12	JSPRJasper Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−37.1K sh	$0.85	−$31.6K	250,097
2023-06-13	JSPRJasper Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+9,000 sh	$0.71	+$6,390	296,223
2023-06-13	JSPRJasper Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−9,000 sh	$1.66	−$14.9K	287,223
2023-06-13	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+9,000 sh	—	—	173,713
2023-04-12	JSPRJasper Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−37.1K sh	$1.46	−$54.2K	287,223
2023-03-17	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+350K sh	—	—	350,000
2022-10-12	JSPRJasper Therapeutics, Inc.A Award	Director, CEO and President	AAward	+215K sh	—	—	324,349
2022-04-07	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+48.4K sh	—	—	48,441
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+7,500 sh	—	—	7,500
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+87.3K sh	—	—	87,272

Recent filings

Accepted (ET)
Feb 104
Mahal Jeetinder Singh0001213900-26-014244
SEC(opens sec.gov)
Jan 54
Mahal Jeetinder Singh0001213900-26-001383
SEC(opens sec.gov)
Jun 64
Mahal Jeetinder Singh0001213900-25-051726
SEC(opens sec.gov)
Feb 184
Mahal Jeetinder Singh0001213900-25-014951
SEC(opens sec.gov)
Dec 124
Mahal Jeetinder Singh0001213900-24-108551
SEC(opens sec.gov)
Sep 124
Mahal Jeetinder Singh0001213900-24-078214
SEC(opens sec.gov)
Jun 124
Mahal Jeetinder Singh0001213900-24-052215
SEC(opens sec.gov)
Mar 124
Mahal Jeetinder Singh0001213900-24-021961
SEC(opens sec.gov)
Feb 204
Mahal Jeetinder Singh0001213900-24-015462
SEC(opens sec.gov)
Oct 134
Mahal Jeetinder Singh0001013762-23-003903
SEC(opens sec.gov)
Jun 134
Mahal Jeetinder Singh0001213900-23-048683
SEC(opens sec.gov)

Companies

Jasper Therapeutics, Inc.Director, CEO and PresidentJSPR

Address

C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE 102

REDWOOD CITY, CA, 94065